// App-Quantinova.ai

: Predictors of Hematologic Complete Response Achievement and Maintenance in Patients with AL Amyloidosis Treated with Non-Transplant Chemotherapy

Researchers

Presenter

  • Paolo Milani

Principal Investigators

  • Claudia Bellofiore

  • Marco Basset

  • Andrea Foli

  • Pietro Benvenuti

  • Francesca Fabris

  • Martina Nanci

  • Mario Nuvolone

  • Giampaolo Merlini

  • Giovanni Palladini

Medical Centers

  • Department of Molecular Medicine, Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy

  • Amyloidosis Research and Treatment Center, Department of Molecular Medicine, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy

  • Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, ITA

  • Amyloidosis Center, IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy

  • UOC di Ematologia, AOU Policlinico Rodolico San Marco, Catania, Italy

  • Amyloidosis Research and Treatment Center, Pavia, ITA

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • AL Amyloidosis

Biomarkers

  • N-terminal pro b-type natriuretic peptide

Drug/Treatment

  • Alkaline phosphatase

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved